$CLRB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Cellectar Biosciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Cellectar Biosciences, Inc.. Get notifications about new insider transactions in Cellectar Biosciences, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 19 2021 | CLRB | Cellectar Bioscien ... | NEIS JOHN | Director | Option Exercise | S | 30.40 | 23,232 | 706,253 | 0 | |
Mar 19 2021 | CLRB | Cellectar Bioscien ... | NEIS JOHN | Director | Option Exercise | S | 30.40 | 58,640 | 1,782,656 | 23,232 | |
Mar 16 2021 | CLRB | Cellectar Bioscien ... | NEIS JOHN | Director | Option Exercise | S | 30.40 | 100,515 | 3,055,656 | 81,872 | |
Mar 16 2021 | CLRB | Cellectar Bioscien ... | NEIS JOHN | Director | Option Exercise | S | 30.40 | 11,200 | 340,480 | 182,387 | |
Mar 16 2021 | CLRB | Cellectar Bioscien ... | NEIS JOHN | Director | Option Exercise | S | 30.40 | 41,155 | 1,251,112 | 193,587 | |
Mar 05 2021 | CLRB | Cellectar Bioscien ... | Elefant Dov | Chief Financial Off ... | Option Exercise | A | 1.74 | 430,000 | 748,200 | 430,000 | |
Mar 05 2021 | CLRB | Cellectar Bioscien ... | Longcor Jarrod | Chief Business Offi ... | Option Exercise | A | 1.74 | 450,000 | 783,000 | 450,000 | |
Mar 05 2021 | CLRB | Cellectar Bioscien ... | Friend John E. II | Chief Medical Offic ... | Option Exercise | A | 1.74 | 330,000 | 574,200 | 330,000 | |
Mar 05 2021 | CLRB | Cellectar Bioscien ... | CARUSO JAMES V | President and CEO | Option Exercise | S | 30.40 | 46,948 | 1,427,219 | 0 | |
Mar 05 2021 | CLRB | Cellectar Bioscien ... | CARUSO JAMES V | President and CEO | Option Exercise | A | 1.74 | 1,600,000 | 2,784,000 | 1,600,000 | |
Mar 05 2021 | CLRB | Cellectar Bioscien ... | CARUSO JAMES V | President and CEO | Buy | P | 1.70 | 5,100 | 8,659 | 86,401 | 81.3 K to 86.4 K (+6.27 %) |
Dec 28 2020 | CLRB | Cellectar Bioscien ... | CARUSO JAMES V | President and CEO | Buy | P | 1.35 | 37,037 | 50,000 | 81,301 | 44.3 K to 81.3 K (+83.67 %) |
Dec 28 2020 | CLRB | Cellectar Bioscien ... | Longcor Jarrod | Chief Business Offi ... | Buy | P | 1.35 | 29,630 | 40,001 | 102,148 | 72.5 K to 102.1 K (+40.86 %) |
Dec 28 2020 | CLRB | Cellectar Bioscien ... | Elefant Dov | Chief Financial Off ... | Buy | P | 1.35 | 7,407 | 9,999 | 11,755 | 4.3 K to 11.8 K (+170.35 %) |
Jul 06 2020 | CLRB | Cellectar Bioscien ... | Friend John E. II | VP, Chief Medical O ... | Option Exercise | A | 1.34 | 100,000 | 134,000 | 100,000 | |
Jun 25 2020 | CLRB | Cellectar Bioscien ... | Loren Stefan | Director | Option Exercise | A | 1.28 | 50,000 | 64,000 | 50,000 | |
Jun 25 2020 | CLRB | Cellectar Bioscien ... | NEIS JOHN | Director | Option Exercise | A | 1.28 | 50,000 | 64,000 | 50,000 | |
Jun 25 2020 | CLRB | Cellectar Bioscien ... | HILL STEPHEN A | Director | Option Exercise | A | 1.28 | 50,000 | 64,000 | 50,000 | |
Jun 25 2020 | CLRB | Cellectar Bioscien ... | Swirsky Douglas J | Director | Option Exercise | A | 1.28 | 80,000 | 102,400 | 80,000 | |
Jun 25 2020 | CLRB | Cellectar Bioscien ... | DRISCOLL FREDERICK W | Director | Option Exercise | A | 1.28 | 50,000 | 64,000 | 50,000 | |
Jun 08 2020 | CLRB | Cellectar Bioscien ... | HILL STEPHEN A | Director | Buy | P | 1.08 | 18,000 | 19,438 | 18,000 | 0 to 18 K |
Jun 08 2020 | CLRB | Cellectar Bioscien ... | Elefant Dov | Chief Financial Off ... | Option Exercise | P | 1.21 | 2,174 | 2,625 | 2,174 | |
Jun 08 2020 | CLRB | Cellectar Bioscien ... | Elefant Dov | Chief Financial Off ... | Buy | P | 1.15 | 4,348 | 4,978 | 4,348 | 0 to 4.3 K |
Jun 08 2020 | CLRB | Cellectar Bioscien ... | Longcor Jarrod | Chief Business Offi ... | Option Exercise | P | 1.21 | 32,609 | 39,375 | 32,609 | |
Jun 08 2020 | CLRB | Cellectar Bioscien ... | Longcor Jarrod | Chief Business Offi ... | Buy | P | 1.15 | 65,218 | 74,675 | 72,518 | 7.3 K to 72.5 K (+893.40 %) |
Jun 08 2020 | CLRB | Cellectar Bioscien ... | CARUSO JAMES V | President and CEO | Option Exercise | P | 1.21 | 10,870 | 13,126 | 10,870 | |
Jun 08 2020 | CLRB | Cellectar Bioscien ... | CARUSO JAMES V | President and CEO | Buy | P | 1.15 | 21,740 | 24,892 | 44,264 | 22.5 K to 44.3 K (+96.52 %) |
Feb 04 2020 | CLRB | Cellectar Bioscien ... | Elefant Dov | Chief Financial Off ... | Grant | A | 2.71 | 10,000 | 27,100 | 10,000 | 0 to 10 K |
Feb 04 2020 | CLRB | Cellectar Bioscien ... | Longcor Jarrod | Chief Business Offi ... | Grant | A | 2.71 | 40,000 | 108,400 | 40,000 | 0 to 40 K |
Feb 04 2020 | CLRB | Cellectar Bioscien ... | CARUSO JAMES V | President and CEO | Grant | A | 2.71 | 100,000 | 271,000 | 100,000 | 0 to 100 K |
Jan 08 2020 | CLRB | Cellectar Bioscien ... | Grachev Igor D | Chief Medical Offic ... | Option Exercise | A | 2.46 | 80,000 | 196,800 | 80,000 | |
Sep 11 2019 | CLRB | Cellectar Bioscien ... | Elefant Dov | Chief Financial Off ... | Option Exercise | A | 2.32 | 90,000 | 208,800 | 90,000 | |
Jun 14 2019 | CLRB | Cellectar Bioscien ... | HILL STEPHEN A | Director | Option Exercise | A | 2.15 | 6,500 | 13,975 | 6,500 | |
Jun 14 2019 | CLRB | Cellectar Bioscien ... | DRISCOLL FREDERICK W | Director | Option Exercise | A | 2.15 | 6,500 | 13,975 | 6,500 | |
Jun 14 2019 | CLRB | Cellectar Bioscien ... | Loren Stefan | Director | Option Exercise | A | 2.15 | 6,500 | 13,975 | 6,500 | |
Jun 14 2019 | CLRB | Cellectar Bioscien ... | NEIS JOHN | Director | Option Exercise | A | 2.15 | 6,500 | 13,975 | 6,500 | |
Jun 14 2019 | CLRB | Cellectar Bioscien ... | Swirsky Douglas J | Director | Option Exercise | A | 2.15 | 9,750 | 20,963 | 9,750 | |
Mar 01 2019 | CLRB | Cellectar Bioscien ... | Longcor Jarrod | Chief Business Offi ... | Buy | P | 2.00 | 100 | 200 | 7,300 | 7.2 K to 7.3 K (+1.39 %) |
Jan 18 2019 | CLRB | Cellectar Bioscien ... | Longcor Jarrod | Chief Business Offi ... | Option Exercise | A | 1.99 | 30,000 | 59,700 | 30,000 | |
Jan 18 2019 | CLRB | Cellectar Bioscien ... | POSNER BRIAN M | Chief Financial Off ... | Option Exercise | A | 1.99 | 30,000 | 59,700 | 30,000 | |
Jan 18 2019 | CLRB | Cellectar Bioscien ... | CARUSO JAMES V | President and CEO | Option Exercise | A | 1.99 | 75,000 | 149,250 | 75,000 | |
Nov 30 2018 | CLRB | Cellectar Bioscien ... | CARUSO JAMES V | President and CEO | Buy | P | 2.28 | 1,000 | 2,282 | 22,354 | 21.4 K to 22.4 K (+4.68 %) |
Nov 30 2018 | CLRB | Cellectar Bioscien ... | HILL STEPHEN A | Director | Option Exercise | S | 468.00 | 530 | 248,040 | 0 | |
Nov 30 2018 | CLRB | Cellectar Bioscien ... | HILL STEPHEN A | Director | Option Exercise | S | 30.40 | 9,390 | 285,456 | 0 | |
Nov 30 2018 | CLRB | Cellectar Bioscien ... | HILL STEPHEN A | Director | Sell | S | 2.21 | 53 | 117 | 0 | 53 to 0 (-100.00 %) |
Nov 30 2018 | CLRB | Cellectar Bioscien ... | HILL STEPHEN A | Director | Sell | S | 2.21 | 939 | 2,075 | 53 | 992 to 53 (-94.66 %) |
Oct 15 2018 | CLRB | Cellectar Bioscien ... | NEIS JOHN | Director | Option Exercise | A | 2.61 | 13,000 | 33,930 | 13,000 | |
Oct 15 2018 | CLRB | Cellectar Bioscien ... | NEIS JOHN | Director | Option Exercise | A | 2.61 | 13,000 | 33,930 | 13,000 | |
Oct 15 2018 | CLRB | Cellectar Bioscien ... | Loren Stefan | Director | Option Exercise | A | 2.61 | 13,000 | 33,930 | 13,000 | |
Oct 15 2018 | CLRB | Cellectar Bioscien ... | Loren Stefan | Director | Option Exercise | A | 2.61 | 13,000 | 33,930 | 13,000 | |
Oct 15 2018 | CLRB | Cellectar Bioscien ... | HILL STEPHEN A | Director | Option Exercise | A | 2.61 | 13,000 | 33,930 | 13,000 | |
Oct 15 2018 | CLRB | Cellectar Bioscien ... | HILL STEPHEN A | Director | Option Exercise | A | 2.61 | 13,000 | 33,930 | 13,000 | |
Oct 15 2018 | CLRB | Cellectar Bioscien ... | DRISCOLL FREDERICK W | Director | Option Exercise | A | 2.61 | 13,000 | 33,930 | 13,000 | |
Oct 15 2018 | CLRB | Cellectar Bioscien ... | DRISCOLL FREDERICK W | Director | Option Exercise | A | 2.61 | 13,000 | 33,930 | 13,000 | |
Oct 15 2018 | CLRB | Cellectar Bioscien ... | Swirsky Douglas J | Director | Option Exercise | A | 2.61 | 19,500 | 50,895 | 19,500 | |
Oct 15 2018 | CLRB | Cellectar Bioscien ... | Swirsky Douglas J | Director | Option Exercise | A | 2.61 | 19,500 | 50,895 | 19,500 | |
Oct 15 2018 | CLRB | Cellectar Bioscien ... | POSNER BRIAN M | Chief Financial Off ... | Option Exercise | A | 2.61 | 54,000 | 140,940 | 54,000 | |
Oct 15 2018 | CLRB | Cellectar Bioscien ... | POSNER BRIAN M | Chief Financial Off ... | Option Exercise | A | 2.61 | 54,000 | 140,940 | 54,000 | |
Oct 15 2018 | CLRB | Cellectar Bioscien ... | Friend John E. II | Chief Medical Offic ... | Option Exercise | A | 2.61 | 63,000 | 164,430 | 63,000 | |
Oct 15 2018 | CLRB | Cellectar Bioscien ... | Friend John E. II | Chief Medical Offic ... | Option Exercise | A | 2.61 | 63,000 | 164,430 | 63,000 | |
Oct 15 2018 | CLRB | Cellectar Bioscien ... | Longcor Jarrod | Chief Business Offi ... | Option Exercise | A | 2.61 | 63,000 | 164,430 | 63,000 | |
Oct 15 2018 | CLRB | Cellectar Bioscien ... | Longcor Jarrod | Chief Business Offi ... | Option Exercise | A | 2.61 | 63,000 | 164,430 | 63,000 | |
Oct 15 2018 | CLRB | Cellectar Bioscien ... | CARUSO JAMES V | President and CEO | Option Exercise | A | 2.61 | 150,000 | 391,500 | 150,000 | |
Oct 15 2018 | CLRB | Cellectar Bioscien ... | CARUSO JAMES V | President and CEO | Option Exercise | A | 2.61 | 150,000 | 391,500 | 150,000 | |
Aug 17 2018 | CLRB | Cellectar Bioscien ... | Longcor Jarrod | Chief Business Offi ... | Buy | P | 2.71 | 500 | 1,355 | 7,200 | 6.7 K to 7.2 K (+7.46 %) |
Apr 06 2018 | CLRB | Cellectar Bioscien ... | POSNER BRIAN M | Chief Financial Off ... | Option Exercise | A | 1.17 | 80,000 | 93,600 | 80,000 | |
Mar 14 2018 | CLRB | Cellectar Bioscien ... | Longcor Jarrod | Chief Business Offi ... | Sell | S | 1.18 | 13,000 | 15,397 | 67,000 | 80 K to 67 K (-16.25 %) |
Mar 14 2018 | CLRB | Cellectar Bioscien ... | CARUSO JAMES V | President and CEO | Sell | S | 1.20 | 34,000 | 40,705 | 213,548 | 247.5 K to 213.5 K (-13.73 %) |
Nov 16 2017 | CLRB | Cellectar Bioscien ... | NEIS JOHN | Director | Sell | S | 1.49 | 5,214 | 7,791 | 626,103 | 631.3 K to 626.1 K (-0.83 %) |
Sep 25 2017 | CLRB | Cellectar Bioscien ... | Longcor Jarrod | Chief Business Offi ... | Option Exercise | A | 1.83 | 25,000 | 45,750 | 25,000 | |
Jun 01 2017 | CLRB | Cellectar Bioscien ... | HILL STEPHEN A | Director | Option Exercise | A | 1.74 | 10,000 | 17,400 | 10,000 | |
Jun 01 2017 | CLRB | Cellectar Bioscien ... | DRISCOLL FREDERICK W | Director | Option Exercise | A | 1.74 | 10,000 | 17,400 | 10,000 | |
Jun 01 2017 | CLRB | Cellectar Bioscien ... | NEIS JOHN | Director | Option Exercise | A | 1.74 | 10,000 | 17,400 | 10,000 | |
Jun 01 2017 | CLRB | Cellectar Bioscien ... | Loren Stefan | Director | Option Exercise | A | 1.74 | 10,000 | 17,400 | 10,000 | |
Jun 01 2017 | CLRB | Cellectar Bioscien ... | Swirsky Douglas J | Director | Option Exercise | A | 1.74 | 10,000 | 17,400 | 10,000 | |
Apr 20 2017 | CLRB | Cellectar Bioscien ... | Kolean Chad J | VP, Chief Financial ... | Grant | A | 0.00 | 80,000 | 0 | 80,000 | 0 to 80 K |
Apr 20 2017 | CLRB | Cellectar Bioscien ... | Longcor Jarrod | Sr. VP of Corp Dev ... | Grant | A | 0.00 | 80,000 | 0 | 80,000 | 0 to 80 K |
Apr 20 2017 | CLRB | Cellectar Bioscien ... | CARUSO JAMES V | President and CEO | Grant | A | 0.00 | 200,000 | 0 | 247,548 | 47.5 K to 247.5 K (+420.63 %) |
Apr 18 2017 | CLRB | Cellectar Bioscien ... | Friend John E. II | VP, Chief Medical O ... | Grant | A | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
Nov 30 2016 | CLRB | Cellectar Bioscien ... | NEIS JOHN | Director | Option Exercise | P | 1.50 | 333,333 | 500,000 | 607,946 | |
Nov 30 2016 | CLRB | Cellectar Bioscien ... | NEIS JOHN | Director | Buy | P | 1.49 | 333,333 | 496,666 | 631,317 | 298 K to 631.3 K (+111.86 %) |
Nov 01 2016 | CLRB | Cellectar Bioscien ... | Hertzberg Richard | Option Exercise | S | 46.80 | 40,916 | 1,914,869 | 0 | ||
Nov 01 2016 | CLRB | Cellectar Bioscien ... | Hertzberg Richard | Sell | S | 2.03 | 21,000 | 42,609 | 280,000 | 301 K to 280 K (-6.98 %) | |
Aug 12 2016 | CLRB | Cellectar Bioscien ... | Longcor Jarrod | Sr. VP of Corp Dev ... | Option Exercise | A | 2.93 | 75,000 | 219,750 | 75,000 | |
Jul 07 2016 | CLRB | Cellectar Bioscien ... | Loren Stefan | Director | Option Exercise | A | 3.34 | 22,500 | 75,150 | 23,500 | |
Jul 06 2016 | CLRB | Cellectar Bioscien ... | NEIS JOHN | Director | Option Exercise | A | 3.34 | 22,500 | 75,150 | 24,750 | |
Jul 06 2016 | CLRB | Cellectar Bioscien ... | HILL STEPHEN A | Director | Option Exercise | A | 3.34 | 22,500 | 75,150 | 25,434 | |
Jun 14 2016 | CLRB | Cellectar Bioscien ... | Hertzberg Richard | Option Exercise | P | 3.04 | 234,742 | 713,616 | 41,915 | ||
Jun 14 2016 | CLRB | Cellectar Bioscien ... | Hertzberg Richard | Buy | P | 1.90 | 3,758 | 7,140 | 301,000 | 297.2 K to 301 K (+1.26 %) | |
Jun 14 2016 | CLRB | Cellectar Bioscien ... | Hertzberg Richard | Buy | P | 2.12 | 234,742 | 497,653 | 297,242 | 62.5 K to 297.2 K (+375.59 %) | |
May 23 2016 | CLRB | Cellectar Bioscien ... | CARUSO JAMES V | President and CEO | Option Exercise | A | 1.48 | 200,000 | 296,000 | 237,500 | |
May 23 2016 | CLRB | Cellectar Bioscien ... | Weichert Jamey P | Chief Scientific Of ... | Option Exercise | A | 1.48 | 40,000 | 59,200 | 42,895 | |
May 23 2016 | CLRB | Cellectar Bioscien ... | Kolean Chad J | VP, CFO and Treasur ... | Option Exercise | A | 1.48 | 50,000 | 74,000 | 52,000 | |
Apr 21 2016 | CLRB | Cellectar Bioscien ... | HILL STEPHEN A | Director | Option Exercise | P | 3.04 | 9,390 | 28,546 | 9,920 | |
Apr 21 2016 | CLRB | Cellectar Bioscien ... | HILL STEPHEN A | Director | Buy | P | 2.12 | 9,390 | 19,907 | 9,920 | 530 to 9.9 K (+1,771.70 %) |
Apr 21 2016 | CLRB | Cellectar Bioscien ... | NEIS JOHN | Director | Option Exercise | P | 3.04 | 234,742 | 713,616 | 274,613 | |
Apr 21 2016 | CLRB | Cellectar Bioscien ... | NEIS JOHN | Director | Buy | P | 2.12 | 234,742 | 497,653 | 297,984 | 63.2 K to 298 K (+371.18 %) |
Apr 21 2016 | CLRB | Cellectar Bioscien ... | BERNS PAUL L | Director | Option Exercise | P | 3.04 | 117,371 | 356,808 | 117,371 | |
Apr 21 2016 | CLRB | Cellectar Bioscien ... | BERNS PAUL L | Director | Buy | P | 2.12 | 117,371 | 248,827 | 117,371 | 0 to 117.4 K |
Apr 21 2016 | CLRB | Cellectar Bioscien ... | CARUSO JAMES V | President and CEO | Option Exercise | P | 3.04 | 46,948 | 142,722 | 46,948 | |
Apr 21 2016 | CLRB | Cellectar Bioscien ... | CARUSO JAMES V | President and CEO | Buy | P | 2.12 | 46,948 | 99,530 | 47,548 | 600 to 47.5 K (+7,824.67 %) |
Dec 08 2015 | CLRB | Cellectar Bioscien ... | AWM Investment Company, Inc. | 10% Owner | Sell | S | 1.06 | 49,950 | 53,042 | 702,562 | 752.5 K to 702.6 K (-6.64 %) |
Dec 08 2015 | CLRB | Cellectar Bioscien ... | AWM Investment Company, Inc. | 10% Owner | Sell | S | 1.14 | 1,000 | 1,140 | 752,512 | 753.5 K to 752.5 K (-0.13 %) |
Jan 04 2016 | CLRB | Cellectar Bioscien ... | AWM Investment Company, Inc. | 10% Owner | Sell | S | 0.70 | 35,253 | 24,518 | 0 | 35.3 K to 0 (-100.00 %) |
Jan 04 2016 | CLRB | Cellectar Bioscien ... | AWM Investment Company, Inc. | 10% Owner | Sell | S | 0.69 | 64,747 | 44,501 | 35,253 | 100 K to 35.3 K (-64.75 %) |
Dec 30 2015 | CLRB | Cellectar Bioscien ... | AWM Investment Company, Inc. | 10% Owner | Sell | S | 0.69 | 82,847 | 57,405 | 100,000 | 182.8 K to 100 K (-45.31 %) |
Dec 29 2015 | CLRB | Cellectar Bioscien ... | AWM Investment Company, Inc. | 10% Owner | Sell | S | 0.69 | 150,975 | 104,218 | 182,847 | 333.8 K to 182.8 K (-45.23 %) |
Dec 29 2015 | CLRB | Cellectar Bioscien ... | AWM Investment Company, Inc. | 10% Owner | Sell | S | 0.76 | 216,991 | 164,826 | 333,822 | 550.8 K to 333.8 K (-39.39 %) |
Dec 23 2015 | CLRB | Cellectar Bioscien ... | AWM Investment Company, Inc. | 10% Owner | Sell | S | 0.90 | 7,938 | 7,181 | 550,813 | 558.8 K to 550.8 K (-1.42 %) |
Dec 22 2015 | CLRB | Cellectar Bioscien ... | AWM Investment Company, Inc. | 10% Owner | Sell | S | 0.92 | 20,621 | 19,019 | 558,751 | 579.4 K to 558.8 K (-3.56 %) |
Dec 22 2015 | CLRB | Cellectar Bioscien ... | AWM Investment Company, Inc. | 10% Owner | Sell | S | 0.90 | 7,000 | 6,292 | 579,372 | 586.4 K to 579.4 K (-1.19 %) |
Dec 18 2015 | CLRB | Cellectar Bioscien ... | AWM Investment Company, Inc. | 10% Owner | Sell | S | 0.88 | 18,240 | 16,080 | 586,372 | 604.6 K to 586.4 K (-3.02 %) |
Dec 18 2015 | CLRB | Cellectar Bioscien ... | AWM Investment Company, Inc. | 10% Owner | Sell | S | 0.86 | 52,985 | 45,800 | 604,612 | 657.6 K to 604.6 K (-8.06 %) |
Dec 16 2015 | CLRB | Cellectar Bioscien ... | AWM Investment Company, Inc. | 10% Owner | Sell | S | 0.82 | 44,965 | 37,065 | 657,597 | 702.6 K to 657.6 K (-6.40 %) |
Dec 03 2015 | CLRB | Cellectar Bioscien ... | AWM Investment Company, Inc. | 10% Owner | Sell | S | 1.04 | 42,110 | 43,815 | 753,512 | 795.6 K to 753.5 K (-5.29 %) |
Dec 01 2015 | CLRB | Cellectar Bioscien ... | AWM Investment Company, Inc. | 10% Owner | Sell | S | 1.20 | 4,378 | 5,265 | 795,622 | 800 K to 795.6 K (-0.55 %) |
Nov 25 2015 | CLRB | Cellectar Bioscien ... | AWM Investment Company, Inc. | 10% Owner | Sell | S | 1.27 | 67,102 | 85,535 | 800,000 | 867.1 K to 800 K (-7.74 %) |
Nov 25 2015 | CLRB | Cellectar Bioscien ... | AWM Investment Company, Inc. | 10% Owner | Sell | S | 1.21 | 106,700 | 129,214 | 867,102 | 973.8 K to 867.1 K (-10.96 %) |
Nov 25 2015 | CLRB | Cellectar Bioscien ... | CARUSO JAMES V | President and CEO | Buy | P | 1.30 | 1,000 | 1,302 | 6,000 | 5 K to 6 K (+20.00 %) |
Nov 24 2015 | CLRB | Cellectar Bioscien ... | CARUSO JAMES V | President and CEO | Buy | P | 1.16 | 1,000 | 1,159 | 5,000 | 4 K to 5 K (+25.00 %) |
Nov 23 2015 | CLRB | Cellectar Bioscien ... | AWM Investment Company, Inc. | 10% Owner | Sell | S | 1.15 | 88,745 | 102,216 | 973,802 | 1.1 M to 973.8 K (-8.35 %) |
Nov 23 2015 | CLRB | Cellectar Bioscien ... | AWM Investment Company, Inc. | 10% Owner | Sell | S | 1.38 | 8,061 | 11,119 | 10,625,547 | 10.6 M to 10.6 M (-0.08 %) |
Nov 19 2015 | CLRB | Cellectar Bioscien ... | CARUSO JAMES V | President and CEO | Buy | P | 1.50 | 2,000 | 3,000 | 4,000 | 2 K to 4 K (+100.00 %) |
Nov 19 2015 | CLRB | Cellectar Bioscien ... | CARUSO JAMES V | President and CEO | Buy | P | 1.39 | 2,000 | 2,790 | 2,000 | 0 to 2 K |
Oct 29 2015 | CLRB | Cellectar Bioscien ... | AWM Investment Company, Inc. | 10% Owner | Sell | S | 2.00 | 99 | 198 | 1,070,608 | 1.1 M to 1.1 M (-0.01 %) |
Oct 26 2015 | CLRB | Cellectar Bioscien ... | AWM Investment Company, Inc. | 10% Owner | Sell | S | 2.00 | 2,000 | 4,000 | 1,070,707 | 1.1 M to 1.1 M (-0.19 %) |
Oct 26 2015 | CLRB | Cellectar Bioscien ... | AWM Investment Company, Inc. | 10% Owner | Sell | S | 2.00 | 6,866 | 13,732 | 1,072,707 | 1.1 M to 1.1 M (-0.64 %) |
Oct 08 2015 | CLRB | Cellectar Bioscien ... | AWM Investment Company, Inc. | 10% Owner | Sell | S | 2.00 | 2,554 | 5,108 | 1,079,573 | 1.1 M to 1.1 M (-0.24 %) |
Oct 06 2015 | CLRB | Cellectar Bioscien ... | AWM Investment Company, Inc. | 10% Owner | Sell | S | 2.11 | 2,800 | 5,903 | 1,082,127 | 1.1 M to 1.1 M (-0.26 %) |
Oct 06 2015 | CLRB | Cellectar Bioscien ... | AWM Investment Company, Inc. | 10% Owner | Sell | S | 2.00 | 4,700 | 9,400 | 1,084,927 | 1.1 M to 1.1 M (-0.43 %) |
Oct 02 2015 | CLRB | Cellectar Bioscien ... | AWM Investment Company, Inc. | 10% Owner | Sell | S | 2.06 | 21,600 | 44,494 | 1,089,627 | 1.1 M to 1.1 M (-1.94 %) |
Oct 02 2015 | CLRB | Cellectar Bioscien ... | AWM Investment Company, Inc. | 10% Owner | Sell | S | 2.00 | 6,340 | 12,680 | 1,111,227 | 1.1 M to 1.1 M (-0.57 %) |
Sep 30 2015 | CLRB | Cellectar Bioscien ... | AWM Investment Company, Inc. | 10% Owner | Sell | S | 2.15 | 1,701 | 3,657 | 1,117,567 | 1.1 M to 1.1 M (-0.15 %) |
Sep 30 2015 | CLRB | Cellectar Bioscien ... | AWM Investment Company, Inc. | 10% Owner | Sell | S | 2.65 | 10,000 | 26,500 | 1,119,268 | 1.1 M to 1.1 M (-0.89 %) |
Sep 30 2015 | CLRB | Cellectar Bioscien ... | AWM Investment Company, Inc. | 10% Owner | Sell | S | 2.17 | 13,100 | 28,426 | 1,129,268 | 1.1 M to 1.1 M (-1.15 %) |
Jun 10 2015 | CLRB | Cellectar Bioscien ... | HILL STEPHEN A | Director | Option Exercise | A | 2.64 | 5,000 | 13,200 | 5,000 | |
Jun 10 2015 | CLRB | Cellectar Bioscien ... | NEIS JOHN | Director | Option Exercise | A | 2.64 | 5,000 | 13,200 | 5,000 | |
Jun 10 2015 | CLRB | Cellectar Bioscien ... | BERNS PAUL L | Director | Option Exercise | A | 2.64 | 5,000 | 13,200 | 5,000 | |
Mar 04 2015 | CLRB | Cellectar Bioscien ... | HILL STEPHEN A | Director | Option Exercise | A | 2.69 | 5,500 | 14,795 | 5,500 | |
Mar 04 2015 | CLRB | Cellectar Bioscien ... | NEIS JOHN | Director | Option Exercise | A | 2.69 | 5,000 | 13,450 | 5,000 | |
Mar 04 2015 | CLRB | Cellectar Bioscien ... | Genn John Patrick | VP of Business Deve ... | Option Exercise | A | 2.69 | 10,000 | 26,900 | 10,000 | |
Mar 04 2015 | CLRB | Cellectar Bioscien ... | BERNS PAUL L | Director | Option Exercise | A | 2.69 | 5,000 | 13,450 | 5,000 | |
Dec 18 2014 | CLRB | Cellectar Bioscien ... | Szakacs Cameron | VP of Clinical Deve ... | Option Exercise | A | 2.74 | 50,000 | 137,000 | 50,000 | |
Sep 10 2014 | CLRB | Cellectar Bioscien ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Buy | P | 3.00 | 182 | 546 | 1,142,368 | 1.1 M to 1.1 M (+0.02 %) |
Sep 09 2014 | CLRB | Cellectar Bioscien ... | Genn John Patrick | VP of Business Deve ... | Option Exercise | P | 4.68 | 10,000 | 46,800 | 77,083 | |
Sep 09 2014 | CLRB | Cellectar Bioscien ... | Genn John Patrick | VP of Business Deve ... | Option Exercise | P | 4.68 | 15,000 | 70,200 | 67,083 | |
Sep 09 2014 | CLRB | Cellectar Bioscien ... | Genn John Patrick | VP of Business Deve ... | Option Exercise | P | 4.68 | 22,000 | 102,960 | 52,083 | |
Sep 09 2014 | CLRB | Cellectar Bioscien ... | Genn John Patrick | VP of Business Deve ... | Option Exercise | P | 4.68 | 3,000 | 14,040 | 30,083 | |
Sep 08 2014 | CLRB | Cellectar Bioscien ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Buy | P | 3.00 | 5,699 | 17,097 | 1,142,186 | 1.1 M to 1.1 M (+0.50 %) |
Sep 08 2014 | CLRB | Cellectar Bioscien ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Buy | P | 3.05 | 65,687 | 200,345 | 1,136,487 | 1.1 M to 1.1 M (+6.13 %) |